LifeVantage announced its financial results for the third fiscal quarter, ending March 31 2026. Gross profit during the quarter was $34.5 million, or 79% of revenue. This is a slight decrease from 81% of revenue in the same period of fiscal 2025, and is primarily due to an allowance for inventory obsolescence related to the MindBody GLP-1 System, as well as increased costs for shipping and warehousing. When adjusted for these considerations, gross profit was 79.4% of revenue.